Literature DB >> 20184807

Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia.

Bjørn H Ebdrup1, Birte Glenthøj, Hans Rasmussen, Bodil Aggernaes, Annika R Langkilde, Olaf B Paulson, Henrik Lublin, Arnold Skimminge, William Baaré.   

Abstract

BACKGROUND: Enlarged ventricles and reduced hippocampal volume are consistently found in patients with first-episode schizophrenia. Studies investigating brain structure in antipsychotic-naive patients have generally focused on the striatum. In this study, we examined whether ventricular enlargement and hippocampal and caudate volume reductions are morphological traits of antipsychotic-naive first-episode schizophrenia.
METHODS: We obtained high-resolution 3-dimensional T1-weighted magnetic resonance imaging scans for 38 antipsychotic-naive first-episode schizophrenia patients and 43 matched healthy controls by use of a 3-T scanner. We warped the brain images to each other by use of a high-dimensional intersubject registration algorithm. We performed voxel-wise group comparisons with permutation tests. We performed small volume correction for the hippocampus, caudate and ventricles by use of a false discovery rate correction (p < 0.05) to control for multiple comparisons. We derived and analyzed estimates of brain structure volumes. We grouped patients as those with (n = 9) or without (n = 29) any lifetime substance abuse to examine the possible effects of substance abuse.
RESULTS: We found that hippocampal and caudate volumes were decreased in patients with first-episode schizophrenia. We found no ventricular enlargement, differences in global volume or significant associations between tissue volume and duration of untreated illness or psychopathology. The hippocampal volume reductions appeared to be influenced by a history of substance abuse. Exploratory analyses indicated reduced volume of the nucleus accumbens in patients with first-episode schizophrenia. LIMITATIONS: This study was not a priori designed to test for differences between schizophrenia patients with or without lifetime substance abuse, and this subgroup was small.
CONCLUSION: Reductions in hippocampal and caudate volume may constitute morphological traits in antipsychotic-naive first-episode schizophrenia patients. However, the clinical implications of these findings are unclear. Moreover, past substance abuse may accentuate hippocampal volume reduction. Magnetic resonance imaging studies addressing the potential effects of substance abuse in antipsychotic-naive first-episode schizophrenia patients are warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184807      PMCID: PMC2834791          DOI: 10.1503/jpn.090049

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  48 in total

1.  Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data.

Authors:  Jorge Jovicich; Silvester Czanner; Douglas Greve; Elizabeth Haley; Andre van der Kouwe; Randy Gollub; David Kennedy; Franz Schmitt; Gregory Brown; James Macfall; Bruce Fischl; Anders Dale
Journal:  Neuroimage       Date:  2005-11-21       Impact factor: 6.556

2.  Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images.

Authors:  Meritxell Bach Cuadra; Leila Cammoun; Torsten Butz; Olivier Cuisenaire; Jean-Philippe Thiran
Journal:  IEEE Trans Med Imaging       Date:  2005-12       Impact factor: 10.048

Review 3.  Effects of antipsychotics on brain structure.

Authors:  Harald Scherk; Peter Falkai
Journal:  Curr Opin Psychiatry       Date:  2006-03       Impact factor: 4.741

4.  Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies.

Authors:  A Vita; L De Peri; C Silenzi; M Dieci
Journal:  Schizophr Res       Date:  2005-12-27       Impact factor: 4.939

Review 5.  Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies.

Authors:  R Grant Steen; Courtney Mull; Robert McClure; Robert M Hamer; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2006-06       Impact factor: 9.319

6.  Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia.

Authors:  Benedicto Crespo-Facorro; Roberto Roiz-Santiáñez; José María Pelayo-Terán; Cesar González-Blanch; Rocío Pérez-Iglesias; Agustín Gutiérrez; Enrique Marco de Lucas; Diana Tordesillas; José Luis Vázquez-Barquero
Journal:  Schizophr Res       Date:  2007-02-15       Impact factor: 4.939

7.  Brain volumes in relatives of patients with schizophrenia: a meta-analysis.

Authors:  Heleen B M Boos; André Aleman; Wiepke Cahn; Hilleke Hulshoff Pol; René S Kahn
Journal:  Arch Gen Psychiatry       Date:  2007-03

8.  Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia.

Authors:  Siew E Chua; Charlton Cheung; Vinci Cheung; Jack T K Tsang; Eric Y H Chen; Jason C H Wong; Jason P Y Cheung; Lawrance Yip; Kin-Shing Tai; John Suckling; Gráinne M McAlonan
Journal:  Schizophr Res       Date:  2006-11-13       Impact factor: 4.939

9.  Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.

Authors:  Andreas Glenthoj; Birte Y Glenthoj; Torben Mackeprang; Anne K Pagsberg; Ralf P Hemmingsen; Terry L Jernigan; William F C Baaré
Journal:  Psychiatry Res       Date:  2007-03-13       Impact factor: 3.222

10.  Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Authors:  Dennis Velakoulis; Stephen J Wood; Michael T H Wong; Patrick D McGorry; Alison Yung; Lisa Phillips; De Smith; Warrick Brewer; Tina Proffitt; Patricia Desmond; Christos Pantelis
Journal:  Arch Gen Psychiatry       Date:  2006-02
View more
  42 in total

1.  First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.

Authors:  Kjetil N Jørgensen; Ragnar Nesvåg; Sindre Gunleiksrud; Andrea Raballo; Erik G Jönsson; Ingrid Agartz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-07       Impact factor: 5.270

2.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.

Authors:  Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2016-06-08       Impact factor: 7.853

3.  Pathophysiological distortions in time perception and timed performance.

Authors:  Melissa J Allman; Warren H Meck
Journal:  Brain       Date:  2011-09-15       Impact factor: 13.501

4.  Impact of substance use disorder on gray matter volume in schizophrenia.

Authors:  Margaret Quinn; Maureen McHugo; Kristan Armstrong; Neil Woodward; Jennifer Blackford; Stephan Heckers
Journal:  Psychiatry Res Neuroimaging       Date:  2018-08-03       Impact factor: 2.376

Review 5.  Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Authors:  Kaloyan Rumenov Stoychev
Journal:  Front Psychiatry       Date:  2019-10-23       Impact factor: 4.157

6.  Brain differences in first-episode schizophrenia treated with quetiapine: a deformation-based morphometric study.

Authors:  Chunlan Yang; Shuicai Wu; Wangsheng Lu; Yanping Bai; Hongjian Gao
Journal:  Psychopharmacology (Berl)       Date:  2014-08-02       Impact factor: 4.530

7.  Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental State.

Authors:  Daiki Sasabayashi; Yoichiro Takayanagi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Chika Obara; Masahiro Katsura; Naohiro Okada; Shinsuke Koike; Hidenori Yamasue; Mihoko Nakamura; Atsushi Furuichi; Mikio Kido; Yumiko Nishikawa; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; Kiyoto Kasai; Michio Suzuki
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

8.  Social anhedonia in major depressive disorder: a symptom-specific neuroimaging approach.

Authors:  Verena Enneking; Pia Krüssel; Dario Zaremba; Katharina Dohm; Dominik Grotegerd; Katharina Förster; Susanne Meinert; Christian Bürger; Fanni Dzvonyar; Elisabeth J Leehr; Joscha Böhnlein; Jonathan Repple; Nils Opel; Nils R Winter; Tim Hahn; Ronny Redlich; Udo Dannlowski
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

9.  Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.

Authors:  Nathan L Hutcheson; David G Clark; Mark S Bolding; David M White; Adrienne C Lahti
Journal:  Psychiatry Res       Date:  2013-10-22       Impact factor: 3.222

10.  Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.

Authors:  Bjørn H Ebdrup; Jayachandra M Raghava; Mette Ø Nielsen; Egill Rostrup; Birte Glenthøj
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.